Publications, Pharmaceutical

Developing an In Vitro Dissolution and Release System for Orally Inhaled Drug Products

Robert Price critiques regulatory routes for the development of generic OINDPs, runs through recent announcements and important developments from regulators, and describes how Nanopharm has pioneered the concept of structural Q3 equivalence in orally inhaled drug products.

Download Publication
Author(s): Rob Price
Publication: ONdrugDelivery
1 Apr 2020

Robert Price critiques regulatory routes for the development of generic OINDPs, runs through recent announcements and important developments from regulators, and describes how Nanopharm has pioneered the concept of structural Q3 equivalence in orally inhaled drug products.

DOWNLOAD PUBLICATION

Start a Project With Us

We Thrive on Transforming Ideas into Opportunities – Let Yours be Next.

Contact a Pharma Expert

Back To Top